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ABSTRACT  
Present article explains insect toxins, its immune allergic, pharmaceutical and therapeutic effects. Insect venom glands generate enzymatic and non-
enzymatic toxins and are inflicted by the stings. Insect’s envenomation are highly painful, inflamed and life-threatening. It causes breathing 
difficulties, bronchospasm, hypotension and arrhythmia, cardiopulmonary problems, and imposes allergic reactions. Wasp venom toxins generate 
strong T-cell responses in hypersensitivity patients and stimulate the production of IgE antibody molecules. Massive envenomations causes the 
death of victims due to the toxic effects of the venom toxins if clinical treatment is delayed. This article also emphasizes the role of natural and 
recombinant toxins for the development of highly sensitive immune-assays for diagnosis of allergen-specific tolerance, its early and delayed effects 
in patients to avoid fatal anaphylactic reactions. It also directs about the essentiality of immune diagnostics, vaccines and antiserum therapy in high 
population density regions where incidences of wasp and bee envenomations are more frequently occur. Venom immunotherapy can restore 
normal immunity against venom allergens and may also provide lifetime tolerance against venoms. This article highlights the major effects of insect 
venom allergens, its diagnosis and venom immunotherapy. 
Keywords: Wasps and honeybee, Allergens, Immune-hypersensitivity, Venom immunotherapy 
© 2021 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/) 
DOI: http://dx.doi.org/10.22159/ijpps.2021v13i1.39650. Journal homepage: https://innovareacademics.in/journals/index.php/ijpps.  
 
INTRODUCTION 
Hymenoptera is an order of the class Insecta comprises important 
families, i.e. Apidae, Vespidae, and Myrmicidae. These represent 
venomous insects, including honeybees, bumblebees, paper wasps, 
hornets, ants. These insects possess specialized stinging apparatus 
that is used to inject venom into prey's or intruder's body. Stinging by 
wasps, bees and hornets could be life-threatening for people sensitive 
to the venom. Members of family Apidae and Vespidae inflict stings 
very fast and results in allergic reactions and display fast to delayed 
hypersensitivity reactions. Bumblebees are allergic, but relatively less 
aggressive than wasps and honey bees and largely assist in plant 
pollination [1]. Fire ants are representative of the family Myrmicidae 
and cause local inflammation and its venom is less sensitive than other 
bees and wasps [2]. Hymenopteran stinging evokes hypersensitivity 
that causes a number of deaths in the world than any other 
envenomations [3]. Envenomation by hymenopterans imposes 
anaphylactic effects such as generalized urticaria, bronchospasm, 
hypotension, cardiovascular collapse and loss of consciousness.  
Venom toxins also impose systemic toxic reactions such as edema, 
vomits, diarrhea, headache, hypotension, seizures, altered mental status 
and any unusual reactions such as cardiac ischemia and 
encephalomyelitis that usually lasts for 1-2 d [4]. Anaphylaxis is life-
threatening as imposing cardiopulmonary collapse and generates 
breathing difficulties, bronchospasm, hypotension and arrhythmia [5]. In 
extreme cases, anaphylaxis appeared as systemic symptoms involving 
the gastrointestinal tract, genitourinary tract, or the nervous system. It 
generates a severe systemic reaction in children as they display mild 
eosinophilia, female sex and concomitant atopic diseases [6]. Severity of 
allergy depends on immune tolerance as it is seen in beekeepers, but in 
normal people, it shows an increased risk of sting anaphylaxis due to 
intense allergen exposure, allergy and low-grade systemic reactions [7] 
(table 1). But most deaths occur due to the occurrence of immediate 
hypersensitivity reactions and anaphylaxis. In the present review, 
pharmacological and therapeutic effects of major insect venom toxins 
have been broadly explained for management after stings.  
Source of information  
For writing this comprehensive research review on hymenopteran 
insect toxins/allergens, various databases were searched. For the 
collection of relevant information specific terms such as medical 
subject headings (MeSH) and key text words, such as “venom 
allergens”, “biological and pharmaceutical effects”, venom 
immunotherapy drug development” published till 2020 were used in 
MEDLINE. Most especially for retrieving all articles pertaining to the 
use of VIT for insect venom allergy, electronic bibliographic 
databases were searched and abstracts of published studies with 
relevant information on the venom toxins/allergens were collected. 
Furthermore, additional references were included through 
searching the references cited by the studies done on the present 
topic. Relevant terms were used individually and in combination to 
ensure an extensive literature search. For updating the information 
about a subject and incorporation of recent knowledge, relevant 
research articles, books, conference proceedings’ and public health 
organization survey reports were selected and collated based on the 
broader objective of the review. This was achieved by searching 
databases, including SCOPUS, Web of Science, and EMBASE, Pubmed, 
Swissprot, Google searches. From this common methodology, 
discoveries and findings were identified and summarized in this 
final review. 
Phyiological effects 
Physiologically animal toxins are highly active natural substances 
which bind to various channels and break the normal barrier to the 
free movement of molecules across cell membranes. Venom toxins 
cause enormous hemolysis of RBCs and damage nerve cells. These 
specifically act upon neurons, nicotinic acetylcholine receptors and 
neuromuscular junctions. Hymenopteran venom toxins cause 
hypotensive effects, while a non-enzymatic neurotoxic peptide 
fraction produced the hypertensive effects Phospholipase A, an 
enzymatic toxin, severely acts upon motor nerve terminals and 
muscle cells. It damages skeletal muscles and inhibits cell 
regeneration. Bee venom contains melittin (membranous toxin), 
albumin (neurotoxin), tertiapin, MCD-peptide (mast cell degranulating 
peptide), acidic phosphatase, as well as phospholipase A2 and 
hyaluronidase, both possessing allergenic properties (table 1). 
Melatonin is an enzymatic toxin that hydrolyzes membrane 
phospholipids and form channels through which small molecules 
may pass. Protease inhibitors found in venom bind to protease 
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enzymes and prevent their actions. These inhibit fibrin activity in 
arthritic joints and induce chronic arthritis. 
Various venom toxins isolated from bees, wasps and scorpion 
induces immuno-modulatory, cardio-respiratory, analgesic and 
homeopathic effects. These venom toxins cause sudden 
inflammation in body cells with severe pain and do massive 
inhibition of axonal transmission in neurons. Toxins also change the 
orientation and affinity of ion binding sites and change ion 
permeability mediated by the nicotinic ACH receptors. Different 
animal groups have different channel inhibitors. Some toxins are 
inhibitors of metabolic enzymes and have hydrophobic pockets in 
their secondary structure by which the venom bind at specific 
substrate binding sites. The toxicity of venom depends upon the 
sequence of amino acid residues present in the active site regions, 
topological folding, hydrophobic pockets and binding affinity. The 
mode of action of animal toxins and their physiological 
consequences varies greatly according to the structural variability in 
the active site region (table 1).  
Venoms also cause acute and chronic inflammatory responses in 
laboratory animals. These affect ATP as driven Na+-K+ATPase 
pumps, that plays a key role in maintaining cell volume and 
intracellular ionic composition, specially Na+and K+ gradients is also 
affected. This pump actively transports ions across the cell 
membrane, helps in the excitation of nerves, and does 
phosphorylation and dephosphorylation in muscle cells. In this 
mechanism some transmembrane proteins/enzymes utilize the 
energy stored in molecules of ATP to move K+ into the neuron. Na+-
K+pump assists the neurons in maintain of resting potential for 
which pump allows interior negative charge and exterior positive 
charge on neurons by pumping Na+outside the cell and K+inside the 
cell. Both Na+and K+channels are competitively blocked by these 
toxins, induce the release of transmitters and cause repetitive firing 
of the axons and cause repetitive firing of the axons. Wasp and bee 
envenomation causes severe pain, redness, swelling, heavy 
inflammation, fever, problem in breathing and severe cardiovascular 
problems. Reactions to Hymenoptera stings are classified into 
normal local reactions, large local reactions, and systemic effects. 
However, for therapeutic management stinger is removed out and 
local remedies such as ice-packs, topical steroid epinephrine and 
beta-mimetics, fluid resuscitation, oxygen therapy is provided to 
patient for prevention and treatment of an anaphylactic shock. 
The hymenopteran venom consists of a mixture of biologically active 
substances, such as enzymes phospholipases, hyaluronidases and 
toxin peptides such as mellitins, apamins, mastoparans, bombolitins 
and low-molecular-weight compounds Biogenic amines, 
acetylcholine, carbohydrates, lipids, free amino acids. Predatory 
wasps i.e. hornets (Vespa and Dolico vespula), yellow jackets and 
paper wasps possess amines, small peptides and high molecular 
weight proteins such as enzymes, allergens and toxins [8]. Wasp 
venom contains mastoparan and kinins both generate toxic effect, 
while phospholipase A and B, hyaluronidase, antigen 5, acidic 
phosphatase, and alkaline phosphatase cause allergenic reactions [9, 
10]. Three major allergenic proteins, such as antigen 5, 
phospholipase, and hyaluronidase are found in venom of vespula 
and hornets. While the Dolicho vespula venoms are also allergenic in 
nature [11, 12]. Allergen antigen 5, a hypoallergenic variance is also 
detected in Polibias cutellaris [13] (table 1).  
Venom toxins are primary actors for toxicity in animal venoms [14]. 
These generate severe allergic effects in victims [15]. Wasp sting 
shows nephrotoxicity and impose cortical necrosis (CAN) in the 
kidney [16], severe lung hemorrhage [17], fever [18] systemic 
reactions includes anaphylactic shocks [19] and genotoxic or 
mutagenic effects [20]. Insect venom also possesses vasoactive and 
thrombogenic substances cause vasospasm and coronary 
thrombosis [21]. Stinging by two insects of two different species 
show cross-reactivity and show severe allergic reaction because its 
venoms differs in terms of composition [22]. Bee and bumblebee 
venom allergen show cross-reactivity [23]. Similar cross-reactivity is 
also detected between the venoms of yellow jacket wasps and 
hornets [24]. This cross-reactivity might be due to the similarity of 
epitopes of antigens contained in venoms of various insect species. 
Most common observation about bees, they die immediately after 
injecting venom, while the wasp can sting several times. Bees sting a 
single time, but wasp inflicts venom repetitively but an allergic 
reaction is lower than in the bee [25]. 
Immune allergic responses 
Wasp and bee venom is immunogenic in nature. It induces type I 
reaction, a most common type of immune response which generate 
in initial stage of allergy. The wasp venom generates immediate and 
delayed hypersensitivity reactions that resulted in fatal IgE-
mediated anaphylactic reactions in allergic individuals [26]. Insect 
venoms also cause non-allergic local reactions such as pain, 
small demo, and redness at the site of the sting. First contact with the 
allergen present in the venom leads to the synthesis of specific IgE 
antibodies by allergen sensitized B lymphocytes during generation of 
humoral response. As soon as antigens interact with antibodies 
bound to the surface of mast cells, results in degranulation of these 
cells. These start the release of preformed mediators mainly 
histamine. Some of the other important mediators are 
prostaglandins, leukotrienes which are synthesized de novo. The 
release of these molecules accelerates permeability of capillaries, 
dilatation of venous vessels, and start constriction of bronchial and 
alimentary tract muscular membrane. It is, further, reflected by the 
cascade of clinical signs leading to the anaphylactic reaction. 
Mechanisms leading to the activation of specific IgE synthesis are 
complex. Synthesis of few important molecules interleukins IL-4 and 
IL-13 get increased and IFN-γ is synthesized at a faster rate with the 
surface activation of T cell markers (CD40L and CTLA-4). In 
anaphylaxis important role is played by enhanced synthesis of 
interleukins IL-4 and IL-13, as well as by the predominance of Th2 
phenotype in lymphocyte population. Activation of CD40 on the 
surface of B lymphocyte by its ligands present on the surface of T 
lymphocyte (CD40L) is an interaction required for the formation of 
memory B cells. This reaction leads to the synthesis of antibodies 
against T-cell dependent antigens and inhibits the apoptosis of B 
lymphocytes [27]. 
Pathological signs and symptoms 
Upon infliction, venom causes large local allergic reactions or 
systemic reactions [28] i.e., displayed in form of intradermal lesion 
an itchy wheal, up to 2 cm in diameter which depends on the 
individual sensitization pattern [29]. This is highly painful and 
surrounded by swelling of subcutaneous tissue, up to 10 cm in 
diameter that persists for 24 h. The main symptom of immediate 
type allergy is red, round spots at the site of stinging. Both toxic 
reactions and cytotoxic effects are generated due to the presence of 
specific components of the venom that also causes hemolysis and 
rhabdomyolysis, with subsequent, potentially lethal renal injury 
[30]. Mastoparans and kinins found in wasps venom and both 
generate toxic effects while phospholipase A and B, hyaluronidase, 
antigen 5, acidic phosphatase, and alkaline phosphatase generate 
allergic reactions. Allergic reactions are classified as local or 
systemic. Local allergic reaction pertains to a swelling and rash 
larger than 10 cm and persisting for more than 24 h. More specially, 
stinging within the neck and head regions are potentially most 
dangerous. However, in reality, the swelling resulting from neck 
sting is usually markedly smaller than that located within a limb. 
The clinical effects of a systemic allergic reaction are highly variable 
because of component-specific difference and its interaction. 
Post stinging reactions of hymenopteran are both non-allergic and 
allergic character. These are categorized into four levels or grades. 
In the first level or stage I venom stings causes erythema, pruritis, 
urticaria, Angio-oedema, rhinitis, nausea, intense pain, mild to 
moderate local swelling with redness around the sting site, warmth 
or inflammation at the sting site. Level II or stage II displayed 
asthma, Angio-oedema, abdominal pain, redness and swelling that 
extends beyond the sting site, persists for a couple of days. It 
remains up to 5-10 d. Stage III or level III causes severe breathing or 
respiratory difficulties displayed by Laryngeal edema or asthma, 
marked hypotension, collapse, loss of consciousness, dyspnea, 
laryngeal stridor, dysphagia, dysarthria, dysphonia, and fear of 
death. Stage IV or level IV displays a decrease in arterial pressure, 
collapse, loss of consciousness, urinary and fecal incontinence, and 
cyanosis. The last stage is also specified by systemic allergic reaction 
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or anaphylaxis with swelling of face, throat, lips and tongue, 
restlessness, anxiety, sharp drop in blood pressure, fast pulse and 
dizziness. The patient also gripped in wheezing, dizziness, and lower 
blood pressure, and light-headedness, loss of consciousness, nausea 
or vomiting. Usually, the systemic reaction develops within 10 min 
of stinging [31]. 
Venom composition 
The venom of hymenopterans (bees and wasp) are a complex 
mixture containing proteins, enzymes and small molecules, 
including some of the most dangerous allergens. It 
contains enzymes, non-enzymatic constituents. Hymenoptera venom 
quantity (w/v) differs from species to species, age of the insect. On an 
average the protein content per single injection of venom amounts to 
50–70 μg in the bee, 4. 0–16 μg in the wasp, and 10–30 μg in the 
bumblebee [31]. The venom protein of the hymenopteran is 
categorized in 3 groups. Group A consists of enzymatic components 
such as hyaluronidases, phospholipases, Group B Non-enzymatic 
components (peptide components) such as antigen-5, mastoparans, 
wasp Kinase while group C represents phospholipases, 
hyaluronidases and mastoperans and non-peptidic components like 
alkaloids and polyamines. Hymenoptera venoms each contain a 
variety of protein allergens. Solitary and social wasp venoms include 
hyaluronidase, phospholipase A2, metalloendopeptidase etc. 
Enzymes phospholipase A1, phospholipase A2, acid phosphatase, 
hyaluronidase, serine protease and antigen 5 are common venom 
allergens of hymenopterans [32] (table 1). Many types of enzymes 
found in the Polistes flavus venom such as hydrolases (proteases, 
hyaluronidases, phospholipases and nucleotides) all; these enzymes 
are grouped into hydrolases as well as allergens [33] and toxins 
[34]. The most abundant proteins identified in parasitoid venom are 
hydrolases, such as proteases, peptides, esterases, glycosyl-
hydrolase and endonucleases. Few parasitoid venom proteins 
functions as extracellular superoxide dismutase-3, serine protease 
inhibitor and calreticulin [35]. Fewer toxins possess highly stable 
inhibitors cysteine knot (ICK) motif 2 and 4 disulphide bonds. These 
were found ion channel blockers (neurotoxins) 
and hemolytic agents [36].  
Component specific allergic reactions 
(i) Hyaluronidases 
Hyaluronidases are glycoproteins found in the venom of honey bees, 
wasps and snake venom. These are a family of enzymes 
that catalyze the degradation of hyaluronic acid. Hyaluronidases 
found in almost all venoms and are known as spreading factor. It 
contains N-glycans, which are responsible for allergenicity. It is a 
glycoside hydrolase that breaks β-14 glycosidic bonds between N-
acetylglucosamine and D-glucuronic acids of the hyaluronic acids 
[37]. Hyaluronidases mainly hyaluronoglucosidases (EC 3.2.1.35), 
i.e., cleave the (1->4)-linkages between N-acetylglucosamine and 
glucuronate. They are allergenic factors in the bee and wasp venoms 
and induce severely anaphylactic and IgE-mediated reactions in 
mammals [38]. It initiates the release of histamine from mast cells 
that is responsible for the immediate type of hypersensitivity 
reactions [39]. The hyaluronidases in vespid venoms are similar to 
bee venom hyaluronidase [40]. The enzymes contain significant 
amounts of N-linked carbohydrate [41]. These possess three groups 
of hyaluronidases i. e endo-β-N-acetyl-D-hexosaminidases 
that hydrolyze the higher molecular weight substrates to 
tetrasachharides as the main end products. Second is β-
endoglycoridases group that is detected in leeches and the 
hookworms. The third groups of the losses that act via β-elimination 
yielding disaccharides as the main products reported in bacterial 
hyaluronidases (table 1).  
(ii) Phospholipases 
Phospholipases are lipolytic enzymes that hydrolyze phospholipid 
substrates at specific ester bonds into fatty acids and other lipophilic 
substances. Phospholipases are widespread in nature and play very 
diverse roles, from aggression in snake venom to signal 
transduction, lipid mediator production, and metabolite digestion in 
humans. There are four major classes, termed A, B, C and D, which 
are distinguished by the type of reaction which they catalyze. 
Phospholipase A2 acts on the intact lecithin molecule 
and hydrolyzes the fatty acid esterified to the second carbon atom. 
The resulting products are lysolecithin and a fatty acid. 
Phospholipase A2 is an enzyme present in the venom of bees and 
viper snakes. Phospholipases are enzymes that hydrolyze the ester 
bonds of the phospholipids and fatty acids. 
The wasp venom belongs to a different superfamily than those of 
bees venom phospholipases. Wasp venom phopholipases have PLA, 
PLB specificity and are numbered lipases. Several major 
glycoprotein components have been identified in the venom of bee 
and wasp. The most important specific major components are API m 
1 (phospholipase A2) in the bee, Ves v 1 (phospholipase A1) and Ves 
v 5 (antigen 5) in the wasp. The phospholipids from the Polistes 
venom usually do not contain carbohydrates and have a highly 
homologous region of active sites. The phospholipids of the wasp 
venom digest the cell wall components of diacyphospholipids such 
as phosphotidylcholine, phosphotidylserine, phosphotidyl 
ethanolamine to fatty acids and lysophospholipids with PLAs. The 
phospholipases B is more universally digestive enzymes than PLA1 
and PLA2 and this are present in the venom of yellow wasp Polistes 
flavus (table 1). The phospholipases have not only digestive enzyme, 
but also have hemolytic activities and cardiotoxicity [42]. The 
phospholipase A1 hydrolyzes the ester bonds of the phospholipids 
at the Sn-1 position and produce 2-alkyl-lysophospholipids and fatty 
acids. PLA2 from the Polistes venom disrupt the phospholipids 
packing from several types of biological membranes, leading to 
pores formation and cell-lysis [43]. 
(iii) Antigen 5 
Antigen 5 is a major and most thoroughly studied of the vespid 
venom allergens [44-48]. Antigen 5 is the high molecular weight 
protein but does not contain carbohydrate [48]. Wasp antigen 5 It 
shows the different size in wasp species of different genera. In 
Polistes flavus venom, the antigen 5 has been made up by the 201-
205 amino acids respectively with very high conserve region 
protein. Antigen 5 from Dolicho vespula and the Vespa is not always 
cross-react with antigen 5 from other species of hornets or Vespula 
[48]. The antigen 5 homologs from fire ants do not exhibit antigenic 
cross reactivity with those of vespid wasps [48]. Antigen 5 is a 
venom protein of hornets, yellow jackets and wasps, and it is an 
important allergen for insect-sensitive patients (table 1). Antigen 5s 
from these insects is found to have similar amino-terminal 
sequences for their first 20 residues, and to have similar cyanogen 
bromide cleavage patterns. A partial sequence homology of antigen 
5s and scorpion neurotoxins is observed. Antigen 5s from these 
insects show varying extents of cross-reactivity when tested with 
mouse polyclonal antibodies by enzyme immunoassay. This protein, 
designated as Antigen 5 (Dol m V), has 204-205 amino acid residues 
and it contains 4 disulfide bonds. This protein is an allergen in man, 
but its biological function in hornet is not yet known. 
(iv) Mastoparans 
Mastoparans are low molecular and α-helical polycationic 
amphipathic linear tetradecapeptide amides found in venom of the 
wasp Vespula lewisii [49] (table 1). They are rich in hydrophobic 
leucine, isoleucine, alanine and basic residues, which maintain 
electrostatic interactions with the negatively charged phospholipids 
head groups of the biological membranes [50]. Vespid venoms are 
represented by the mastoparans; it involves a histamine-releasing 
principle. Vespid venoms are represented by the mastoparans, it 
involves a histamine-releasing principle. Mastoparans are 
antimicrobial in nature, causes mast cell degranulation and show 
hemolytic activities [50]. The amphiphilic nature of these peptides 
makes them interact with different types of cell membranes through 
different mechanisms, depending on their primary sequences. Non-
lytic mastoparans may present the ability to interact with different 
types of cell strains, causing minimal membrane reorganization, but 
interact with cell membrane receptors, especially those coupled to 
G-proteins. The high affinity of these receptors makes the 
mastoparans molecules very attractive lead compounds to develop a 
new generation of drugs to modulate the activity of G-proteins-
coupled cell signaling system. Mastoparan stimulates insulin 
secretion from βTC3 and INS-1 cells [50] (table 1). 
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Mastoparan peptide found inserted into the membrane bilayer and 
thus interacts directly with G-proteins on the cytoplasmic face 
attacking the transmembrane signaling and induced by an increase 
in cytoplasmic Ca2+. It is also caused by an increase in the 
intracellular second messenger inositol-1,4,5-triphosphate (IP3) 
[51]. These peptides cause activation of G-protein mediated 
mechanisms, stimulation of phospholipase A2, C and D, mobilization 
of Ca2+from mitochondria and sarcoplasmic reticulum. It also 
activates the ryanodine receptor, modulation of various enzymes, 
such as Na+-K+-ATPase of rat brain, induction of the mitochondrial 
permeability transition and cell death by necrosis and apoptosis 
[52]. Mastoparan induce apoptosis that is initiated by the 
Ca2+release from intracellular release from intracellular stores via 
PLC and IP3. It also causes disruption of plasma membrane integrity 
occurs secondarily [53]. The mastoparans affect intracellular free 
Ca2+concentration in human astrocytoma cells [54] and inhibit 
NMDA receptor-mediated responses and block neurotransmission 
[55]. Functional activities of Ca2+dependent K+ channels increase in 
basilar artery during chronic hypertension caused by wasp 
envenomation [56]. Mastoparan, an activator of GI and mast cells, 
selectively stimulates an PLD2, independently of GI, ADP-
ribosylation factor-1 (ARF-1), protein kinase C and calcium in intact 
cells [57]. PLD is involved in the exocytosis of secretory 
granules of mast cells and neutrophils [58]. Mastoparans found in 
wasp venom is a potent stimulator of exocytosis from diverse 
mammalian cells. It causes secretion of histamine from mast cells, 
serotonin from platelets, catecholamines from chromaffin cells and 
prolactin from the anterior pituitary [59]. 
(v) Wasp-kinins 
Wasps contain a series of different bradykinin related peptides 
in the venom from different species. Wasp kinins are 
polypeptides (9-18 amino acid residues) containing a 
bradykinin-like sequence at the C-terminal. Wasp contains two 
kinins-bradykinin (BK) and lysyl-bradykinin (table 1). These are 
produced in human plasma kallikreins and tissue kallikreins, 
respectively. These are important mediators of inflammatory 
responses, potent pain producers and increase vascular 
permeability and vasodilatation [59-61]. A nonapeptide 
bradykinin found within the wasp-kinin show potent 
pharmacological actions and long-lasting effects. Kinins, such as 
threonine-bradykinin (Thr6-BK) and megascoliakinin (Thr6-BK-
Lys-Ala) and glycosylated wasp-kinins are neurotoxic. Wasp-
kinins are experimentally involved in constriction and relaxation 
of muscles, activation of leukocytes followed by a release of 
cytokines, prostaglandins, leukotrienes, reactive oxygen species 
and the blockage of the cholinergic transmission in the insect 
central nervous system [61].  
Bradykinin a non-peptide also found in body secretions such as 
urine, saliva and sweat. They are also found in several tissues such 
as heart, vasculature, blood, kidney, colon and liver [62]. Bradykinin 
is a potent endothelium-dependent vasodilator and mild diuretic, 
which may cause a lowering of the blood pressure. It also causes 
contraction of non-vascular smooth muscle in the bronchus and gut, 
increases vascular permeability and is also involved in the 
mechanism of pain. In addition to wasp kinins, the wasp venom 
contains a series of hydrophobic peptides, mastoparans and 
chemotactic peptides as major peptidergic components. The first 
major component in the venom is mastoparam. The peptides in the 
mastoparan family are tetradecapeptide amides, which cause 
degranulation of the mast cells to release histamine from the cells, 
and act on the adrenal chromaffin cells to release catecholamines 
and adenylic acids. Some mastoparans cause hemolysis and 
serotonin release from the platelets. The new cytotrophic peptides 
as the second major components are tridecapeptide amides 
possessing chemotactic activity for polymorphonuclear 
leukocytes and monocytes. Some of the peptides in this family also 
cause histamine release from the mast cells. Mastoparan takes a 
random coil structure in aqueous solution but changes its 
conformation to alpha-helix in methanol solution or in the presence 
of lysophosphatidyl choline [62] (table 1).  
(vi) Other bioactive molecules  
There are many other bioactive molecules in the wasp venom 
such as histamine, 5-HT, acetylcholine, tyramine, 
catecholamines, and various peptides. These are only a minor 
portion of the wasp venom. Peptides are major components 
mastoparans, wasp kinins and phospholipases [62]. Besides, 
these several other peptides include protonectin, mandaratoxins 
and chemotactic peptides also found which recruit macrophages 
and polymorphonuclear leukocytes near the site of stinging. 
Protonectins are the mast cell degranulating peptides 
responsible for histamine release. Fewer toxins from the honey 
bees and yellow jacket venom vitellogenins are designated as 
allergens API m 12 and vies v 6 respectively [63]. Their activities 
are very diverse and range from neurotoxic and inflammatory of 
antibacterial activity [64] (table 1). 
Diagnosis of venom induced allergy  
For diagnosis of bees, wasps, and other hymenopteran insect 
induced venom allergy skin and blood tests are performed. 
These tests reveal the presence of allergen-specific IgE 
antibodies in the serum [65]. Skin tests, mainly prick tests and 
intradermal tests are performed at least two weeks after the 
stinging episode. There remains a possibility a risk of a false 
negative result due to the refractory period. For evaluation of 
sensitivity medical history of patients is used to establish 
a diagnosis. Both blood and skin allergy tests can detect a 
patient's sensitivity to insect venoms. 
Skin prick testing 
Skin prick test (SPT) is usually done to identify venom 
induced allergies, mainly based on few systemic reactions [66]. A 
skin prick test is used to identify allergens responsible for 
triggering symptoms in the form of allergic diseases. In SPT skin 
is punctured or scratched by using purified allergen and detect 
immediate allergic reactions. Scratching in adults is usually done 
on the forearm. Skin prick testing is useful in the diagnosis of 
other allergies such as allergens found in bee and wasp venom. 
Skin prick testing is most often used to demonstrate atopy or an 
overactive immune response to environmental factors or to an 
allergen or immunogens. In skin prick tests reactions are 
assessed by the degree of redness and swelling and the size of 
the weal produced. A white, raised edge wheel is formed that 
surrounds the swollen, red central area of any skin reaction. 
Wheal size usually takes about 15-20 min to reach a maximum 
size and thereafter fades over a few hours. The weal size in mm 
of<4 shows a negative result, 5–10-mild sensitive, 10–15-
moderately sensitive, and the largest wheal of 10–15 mm size 
shows high sensitivity to allergens (table 2). 
RAST inhibition test 
RAST or radioallergosorbent test is a radioimmunoassay that 
detects specific IgE or siege antibodies in response to allergen 
and for diagnosis of allergy. RAST (radioallergosorption test) 
test is performed to differentiate genuine dual sensitivity (being 
an indication to immunotherapy with vaccines made of both 
venoms) and cross-reactivity to hyaluronidase or CCD epitopes. 
The precision of results is highly difficult in such tests [67]. 
Obviously, diagnosis of allergy depends on the generation of 
component-specific IgE and monitoring the effects of venom 
immunotherapy in victim [68-70]. It was further modified to 
make more sensitive and named as FAST and ImmunoCAP [71, 
72]. This test shows very high specificity as it binds to allergen-
specific IgE, and extremely sensitive. IgE is the antibody 
associated with Type I allergic response. False-positive results 
may be obtained due to cross-reactivity of homologous proteins 
or by cross-reactive carbohydrate determinants (CCDs) [73]. 
ImmunoCAP and other RAST techniques take longer to perform 
and are less cost-effective. An allergic person remains positive as 
IgE persists for years after exposure. The RAST is scored on a 
scale from 0 to 6 (table 2). 
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Table 1: Important allergens found in hymenopteran venoms 
Hymenopterans species  Allergens  Allergens name  Mol wt. (kD) 
Honey bee 
Apis cerena Api c 1 Phospholipase 16 
Apis mellifera Api m1 Api c1 Phospholipase A2 17 
Apis cerena Api c 2 Hyaluronidase 45 
Apis cerena Api c 4 Melittin 3 
Apis dorsata Api d 1 Phospholipase A2 17 
Apis dorsata Api d 4 Melittin 3 
Apis florae Api fl 4 Melittin 3 
Apis mellifera Api m2 Hyalurodinase 45 
Apis mellifera Api m3 Acid phosphatase 49 
Apis mellifera Api m4 Melittin 3 
Apis mellifera Api m5 DPP IV peptidases IV 100 
Apis mellifera A cerana Api m6 Protease inhibitor 8 
Apis mellifera Api m7 Protease 39 
Apis mellifera Api m8 Carboxylestrase 70 
Apis mellifera Api m9 Carboxypeptidase 60 
Apis mellifera Api m10 CRP/carpin 55 
Apis mellifera Api m 11 0101 MRJP8 65 
Apis mellifera Api m 11 0201 MRJP9 60 
 Apis mellifera Api m12 Vitellogenin 200 
Apis mellifera, A cerana Recombinant MELT Melittin Allergen Api m 3 2.8  
Apis dorsata PLA2 phospholipase-2 39  
Apium graveolens Recombinant Major allergen Api g 1 Profilin 19  
Wasps 
Vespula vulgaris  Ves v1 Ves m1, Ves s1 Phospholipase A1 35 
V flavopilosa Ves v2 0101 Ves m2 Hyalurodinase 45 
V germanica  Ves v2 0201 Hyalurodinase 45 
V maculifrons Ves v3 DPP IV 100 
V pensylvanica Ves v5 Ves Antigen 5 25 
V squamosa Ves v6 Vitellogenin 200 
Vespa crabo Vesp c1, Vesp m1 Phospholipase A1 34 
V mangifica Vesp ma2 Hyalurodinase 35 
V Mandainia Vesp c5, Vesp ma 5 Antigen 5 23 
Hornets 
White-faced hornet Dolichovespula 
maculate 
Dol m1 Phospholipase A1 34 
White-faced hornet Dolichovespula 
maculate 
Dol m2 Hyalurodinase 42 
Yellow hornet D arenaria  Dol m5, Dol a 5 Antigen 5 23 
American paper wasps 
Polistes annularis Pol a1 Pol e 1  34 
P exclamans Pol a2  38 
P fuscatus Pol a4- 
P metricus Pol a 5, Pole5  23 
European paper wasps 
Polistes dominula Pol d1 Pol g1 Phospholipase 34 
Polistes dominula Pol d4 Protease 33 
P gallicus  Pol d5, Pol g5 Antigen 5 23 
Fire ants 
Solenopsis Invicta Soli 1 Phospholipase A1 35 
S germinate Soli 2, Solg2, Sol r2 Sol s 2  14 
S richteri Soli 3, Solg3, Sol r3 Sol s3 Antigen 5 26 
S saevissima Soli 4, Sol g4  12 
 





Allergic reactions Pathological changes/symptoms  References 
Mild+ 5–10 Erythema, pruritis 
urticaria, angioedema, 
rhinitis, nausea 
Intense pain, mild to moderate local swelling with redness around the sting 
site, severe inflammation at the sting site.  
[39] 
Moderate++ 10-15 Asthma, angioedema, 
abdominal pain 
Redness and swelling extends beyond the sting site, persists for a couple of 
days. Take 5-10 d in improvement 
[40] 
Severe+++ 15-20  Patient exhibit wheezing or gasping, dizziness, sudden drop in blood 
pressure, loss of consciousness, severe breathing or respiratory difficulties, 





IMMULITE test shows specificity to insect venom allergen and 
sensitivity [74]. It also displays the presence of IgE against both bee 
and wasp venom. This test is used to explore real cross-reactivity in 
allergic patients to insect venoms. Further, true cross-reactivity is 
displayed as react with carbohydrate epitopes (CCD–Carbohydrate 
Cross-reactive Determinants) of allergens. Positive IgE to both bee 
and wasp venom is often due to cross-reactivity to cross-reactive 
carbohydrate-determining reagents (CCD) [75]. A few specific tests 
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based on recombinant allergens (lacking CCD), are also developed 
for the diagnosis of allergy [75-77]. IMMULITE 2000 Allergy is a 
unique combination of chemiluminescence and liquid allergen 
technology. Both chemiluminescent enzyme immunoassay (CLEIA) 
and CAP test are allergen-specific IgE (sIgE) and assists in asthma, 
allergic rhinitis and atopic dermatitis. For detection of IgM 
antibodies in serum ELISA technique is used [78]. 
For skin testing and serological diagnosis IgE recombinant bee 
and wasp venom allergens are used [79]. Antigen 5 (~23 kDa) 
from Polybia paulista venom (Poly p 5) is a highly abundant and 
glycosylated allergenic protein that could be used for the 
development of component-resolved diagnosis (CRD). Soluble rPoly 
p 5 a recombinant allergen represents a potential candidate for 
molecular diagnosis of Pichia pastoris venom allergy [80]. The use of 
recombinant rapid m 1 and reveals v 5 with the LITE system, 
enhance the diagnostic sensitivity of Immulite testing system. This 
diagnostic utility of venom recombinants has improved allergy 
testing [81]. Level of recombinant allergens used assists in 
interpretation of the test results in routine clinical practice [82]. 
Asymptomatic allergy constitutes an additional significant issue. 
Elevated serum levels of sIgE quite frequently detect in individuals 
with no history of hypersensitivity. In vitro laboratory tests for sIgE 
antibodies together with the skin-prick test (SPT) are routinely used 
in the diagnosis of allergic disorders initiated through a type I 
hypersensitivity mechanism. However, the presence of sIgE is not 
100% specific for the development of symptoms upon allergen 
exposure, but its presence can be viewed as a significant risk factor.  
Basophil activation test (BAT) 
The BAT is a flow cytometry-based assay where the expression of 
activation markers is measured on the surface of basophils following 
stimulation with the allergen. A positive basophil activation test can 
be seen as an in vitro surrogate of an acute allergic reaction in vivo 
Basophil activation test (BAT) test is applied for identification of 
primary sensitizing antigen in Hymenoptera venom allergy [83]. 
This test is based on the activation of patient-derived basophils by 
allergens. In this test, whole blood is stimulated with venoms or 
single allergens and the subsequent activation of basophil is 
measured by the detection of CD63 upregulation on the surface of 
basophil by flow cytometry technique [84]. BAT assists in diagnosis 
of venom allergy in mastocytosis patients with negative sIgE and 
low total IgE. Both side effects and allergen-specific tolerance are 
most important before VIT [85].  
Component-resolved diagnosis 
Component-resolved diagnosis (CRD) is the testing of specific IgE 
reactivity against several single allergens is evolving as a superior 
tool to support classical allergy testing. IgE antibodies directed 
against glycol structures of insect and plant proteins were shown to 
be of high affinity, but their clinical relevance seems to be low, 
meaning that for an unknown reason they are causing no clinical 
symptoms. Component-resolved diagnostics (CRD) is a diagnostic 
approach that utilizes purified native or recombinant allergens to 
detect the sIgE antibodies response against the individual allergenic 
molecule after allergen immunotherapy and to assess venom 
induced anaphylaxis. 
Venom specific immunotherapy  
Allergy to bee and wasp venom can lead to life-threatening systemic 
reactions. For the treatment of bee and wasp venom, envenomation 
venom Immunotherapy (VIT) is applied without any delay (table 3). 
It consists of subcutaneous injections of the increasing amount of 
purified bee and wasp venom extract [86]. Venom-specific 
immunotherapy is highly effective in preventing allergic reactions to 
insect stings and well-tolerated method for immunotherapy [87] 
(table 3). But the appropriate venom must be used to achieve clinical 
protection. Patients which show severe anaphylactic reactions, anti-
immunoglobulin IgE monoclonal antibody omalizumab and VIT 
therapy is used [88] (table 3). Few anti-allergic drugs, 
antihistamines and corticosteroids are also provided to sting 
patients [89] only when they show sting derived-clinical 
manifestations [90]. Anaphylactic side effects are more common 
among patients with mastocytosis [91], in rare cases, a very severe 
reaction can arise [92]. Recurrent systemic anaphylactic side effects 
are rarely a sign of treatment failure. In patients with multiple 
positive results to venoms, molecular allergy diagnostics or CAP-
inhibition may identify the cause venomous. Sometimes special 
clinical protection is required when the victim is attacked and stung 
by two different insect species [93].  
Till date so many major toxins/allergens have been identified in 
many species of wasps and bees, which are of very high medical 
importance. There is need of molecular docking of important data on 
toxins for development of effective therapeutics through 
combination of transcriptomic, proteomic, peptidomic, glycomic and 
venomic approaches [94]. More often, the data available in various 
databases [95] on peptide toxins [96] can be used to develop new 
diagnostic and therapeutic approaches for treatment of poisonous 
animal stings and bites. Production of anti-venom serum against 
important toxins/allergens can be used in immunotherapy to 
encounter envenomation [97]. It is fact that for treatment of severe 
allergies or allergies may not be completely relieved by other 
treatments, hence, allergen immunotherapy can be applied. It 
involves a series of injections of purified allergen extracts, usually 
given over a period of a few years (table 3). 
 
Table 3: Markers of venom immunotherapy 
Types of reaction Venom-specific IgE Venom immunotherapy References 
Severe systemic cardiovascular effects, calcium influx disturbs Positive  Yes [84] 
Moderate systemic light-headedness (angio-oedema, mild asthma or  Positive Sometimes, but usually not [87] 
Mild systemic urticaria, angio-oedema  Positive No [93] 
 
CONCLUSION 
Stinging by insects is known to cause life-threatening allergic 
reactions and impair life quality. Insect venoms are harmful as they 
cause severe toxic and allergic immune effects which persists for 
longer duration. After infliction of venom victims show allergic 
response due to protein in the insect’s saliva and insect venom. It 
causes an immediate allergic reaction and delayed reactions. Venom 
toxins generate strong T-cell responses in hypersensitivity patients 
and interact with IgE antibody molecules. Massive envenomation 
causes death in non-allergic individuals due to the toxic effects of the 
venom. Therefore, to enumerate the allergen-induced local and 
systemic effects and immune responses in victims is highly 
important. Therefore, the development of diagnostic methods able 
to predict the severity of the reaction to future stinging episodes is 
highly needful. Though so many conventional methods are available 
but their precision is not conclusive. However, recombinant antigens 
are to be used to improve both diagnostic and therapeutic methods. 
It will essentially require for substantial improvement of diagnosis 
and therapy of venom allergy.  
Despite the effectiveness of conventional vespid venom 
immunotherapy, more standardized and safer allergy vaccines are 
required and recombinants hypo-allergic variants were found 
important clinical tools. Venom immunotherapy can restore normal 
immunity against venom allergens. It may also provide lifetime 
tolerance against venoms. Hence, it is highly essential and needful to 
monitor the development of tolerance in patients after the VIT 
therapy to avoid fatal anaphylactic reactions. Wasp toxins can be 
used as the most appropriate drug molecules against emerging and 
re-emerging viruses. But it will essentially need the establishment of 
biological activity, validation and clinical development of peptide 
toxins. For proper therapeutics training of health officials is highly 
required for proper diagnosis and management of allergic patients. 
Venom-specific immunotherapy is highly effective as it restores 
pathological effects and causes its reversal.  
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